ReviewDrugs2022

Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors.

Francesco Locatelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.